
With a focus on individualizing patient care and understanding tumor biology, this episode explores the extraordinary transformation of prostate cancer management for patients across Kentucky. Host Dr. Shreyas Kalantri from the University of Cincinnati speaks with oncologist Dr. Chandler Park from the Norton Cancer Institute to discuss the shift from standard androgen deprivation therapy (ADT) to modern doublet and triplet therapies for metastatic hormone-sensitive prostate cancer.
Host: Dr. Shreyas Kalantri, University of Cincinnati
Guest: Dr. Chandler Park, Oncologist, Norton Cancer Institute
The Kentucky Society of Clinical Oncology (KYSCO)
Email: [email protected]
More episodes from "KYSCO Oncology Voices"



Don't miss an episode of “KYSCO Oncology Voices” and subscribe to it in the GetPodcast app.








